Fragment-based approaches and the prospect of fragmented prodrugs

Drug Discovery Today

Volumn 15, Issue 19-20, 2010, Pages 801-803

  Antonow, Dyeison ^a  

^a Cancer Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRODRUG;

DRUG ACTIVITY; DRUG RESEARCH; DRUG SYNTHESIS; EDITORIAL; ENZYME INHIBITION; HUMAN; NONHUMAN;

DRUG DESIGN; DRUG DISCOVERY; HUMANS; INDIVIDUALIZED MEDICINE; MOLECULAR TARGETED THERAPY; PRODRUGS;

EID: 77957683985     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.08.015     Document Type: Editorial

References (11)

1. Fischer M., Hubbard R.E. Mol. Inter. 2009, 9:22-30.
2. de Kloe G.E., et al. Drug Discov. Today 2009, 14:630-646.
3. Chessari G., Woodhead A.J. Drug Discov. Today 2009, 14:668-675.
4. Sharpless K.B., Manetsch R. Expert Opin. Drug Discov. 2006, 1:525-538.
5. Eliseev A.V. Drug Discov. Today 2004, 9:348-349.
6. Chase J.F.A., Tubbs P.K. Biochem. J. 1969, 111:225-235.
7. Rideout D. Science 1986, 233:561-563.
8. Best M.D. Biochemistry 2009, 48:6571-6584.
9. Borman S. Chem. Eng. News 2002, 80:29-34.
10. Lewis W.G., et al. Angew. Chem.-Int. Ed. 2002, 41:1053-1057.
11. Hu X.D., Manetsch R. Chem. Soc. Rev. 2010, 39:1316-1324.